Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 115 full-time employees. The company went IPO on 2005-07-12. The company operates through two reportable segments: healthcare services and product sales. Its businesses include healthcare, medical technology, manufacturing, research and diagnostics, and products and brands. Its specialized primary health care services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, and others. Its products include Terragenx and ProDip (dietary supplement pouches). Terragenx is a micro-dosing IoNovo Iodine product for all ages and lifestyles. Its medical technologies include telemedicine, and remote patient monitoring.
Follow-Up Questions
Qui est le CEO de Novo Integrated Sciences Inc ?
Mr. Robert Mattacchione est le Chairman of the Board de Novo Integrated Sciences Inc, il a rejoint l'entreprise depuis 2018.
Quelle est la performance du prix de l'action NVOS ?
Le prix actuel de NVOS est de $0.0005, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Novo Integrated Sciences Inc ?
Novo Integrated Sciences Inc appartient à l'industrie Health Care et le secteur est Health Care
Quelle est la capitalisation boursière de Novo Integrated Sciences Inc ?
La capitalisation boursière actuelle de Novo Integrated Sciences Inc est de $9865
